Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001104659-24-046549

Director bought 400 shares at $13.32 ($5,327)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Goetz Kathleen Director 2024-04-09 Purchase +400 $13.32 $5,327 1,085.31 D
Open-market purchases · 400 sh · avg $13.32 · $5,327
Loading xslF345X05/tm2411545-2_4seq1.xml…